Market cap
₹36 Cr
Recently Viewed
Clear AllMarket cap
₹36 Cr
Revenue (TTM)
₹72 Cr
P/E Ratio
15.4
P/B Ratio
2.2
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹3 Cr
ROE
18.2 %
ROCE
17.8 %
Industry P/E
44.38
EV/EBITDA
7
Debt to Equity
0.5
Book Value
₹17.6
EPS
₹2.5
Face value
10
Shares outstanding
9,390,440
CFO
₹9.11 Cr
EBITDA
₹15.41 Cr
Net Profit
₹6.06 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Walpar Nutritions
| -20.6 | -- | -- | -23.5 | 2.8 | -- | -- |
|
BSE Healthcare
| 1.8 | 4.5 | 5.7 | 4.6 | 24.6 | 13.6 | 11.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Walpar Nutritions
| -5.2 | 21.9 | 31.3 | 114.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Walpar Nutritions
|
38.0 | 35.7 | 71.8 | 2.8 | -- | 18.2 | 15.4 | 2.2 |
| 5.5 | 6.6 | 0.5 | -0.1 | -89.9 | -- | -- | 0.5 | |
| 24.6 | 14.0 | 8.0 | 0.6 | 13.8 | 5.5 | 22.2 | 1.1 | |
| 661.8 | 8,222.5 | 469.1 | 90.7 | -- | 39 | 90.6 | 19.6 | |
| 238.6 | 310.1 | 127.7 | -24.3 | -20.8 | -325.5 | -- | 62.1 | |
| 24.6 | 42.1 | 49.3 | 0.8 | 1.6 | 4.5 | 55.4 | 2.5 | |
| 43.6 | 42.2 | 67.2 | 2.1 | 3.3 | 4.9 | 20.6 | 1.2 | |
| 205.0 | 322.8 | 162.9 | 9.8 | -- | 32.2 | 32.9 | 6.3 | |
| 128.3 | 82.6 | 65.4 | 2.8 | 6.6 | 12.1 | 29.7 | 3.4 | |
| 195.0 | 205.0 | 89.9 | 7.2 | -- | 13.7 | 28.7 | 3.3 |
No Review & Analysis are available.
Manufacture of pharmaceuticals, medicinal chemical and botanical products
Incorporated
2009
Chairman
--
Managing Director
Kalpesh Ladhawala
Headquarters
Gandhinagar, Gujarat
Website
Looking for more details about Walpar Nutritions Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Walpar Nutritions Ltd is ₹38.00 (NSE) as of 23-Apr-2026 09:42 IST. Walpar Nutritions Ltd has given a return of 2.78% in the last 3 years.
The P/E ratio of Walpar Nutritions Ltd is 15.35 times as on 22-Apr-2026, a 65 discount to its peers’ median range of 44.38 times.
The P/B ratio of Walpar Nutritions Ltd is 2.16 times as on 22-Apr-2026, a 55 discount to its peers’ median range of 4.76 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
17.09
|
2.40
|
|
2024
|
15.62
|
3.49
|
|
2023
|
38.86
|
1.96
|
|
2022
|
32.21
|
1.12
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Walpar Nutritions Ltd are Rs 53.30 and Rs 0.00 as of 23-Apr-2026.
Walpar Nutritions Ltd has a market capitalisation of ₹ 36 Cr as on 22-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Walpar Nutritions Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.